Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/1995
05/31/1995EP0573467B1 NEUROLEPTIC PERHYDRO-1H-PYRIDO 1,2-a]PYRAZINES
05/30/1995US5420297 Peptides having substance P antagonistic activity
05/30/1995US5420158 Melatonin activity
05/30/1995US5420156 Antidepressants an anxiolytic agents
05/30/1995US5420151 Serotonin antagonists
05/30/1995US5420150 Antidepressants and treatment of anxiety
05/30/1995US5420141 Capable of binding to neurotensin receptor
05/30/1995US5420138 Bicyclic pyridines which are angiotensin II inhibitors
05/30/1995US5420134 Substituted hexahydrobenzo[A]phenanthridines
05/30/1995US5419915 Medicament with an analgesic, antipyretic and/or antiphlogistic action and use of 2-ethoxybenzoic acid
05/30/1995CA2136712A1 Piperazine derivatives
05/30/1995CA2066525C Synergistic combinations in the treatment of anxiety
05/30/1995CA2016326C Pyrido-pyridazinone acetic acids for treating chronic diabetic complications
05/27/1995CA2136669A1 1,3,4-oxadiazol-2(3h)-one derivatives, their preparation and their therapeutic application
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014020A1 IMIDAZO[1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS
05/26/1995WO1995014017A1 Non-peptide tachykinin receptor antagonists
05/26/1995WO1995014007A1 Phenyl-alkyl imidazoles as h3-receptor antagonists
05/26/1995WO1995014006A1 OCTAHYDROBENZO[f]QUINOLINE-BASED RECEPTOR AGONISTS AND ANTAGONISTS
05/26/1995WO1995014004A1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d
05/26/1995WO1995013823A1 Method of treating neurological disorders
05/26/1995WO1995013820A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
05/26/1995CA2177046A1 Octahydrobenzo[f]quinoline-based receptor agonists and antagonists
05/26/1995CA2176735A1 Non-peptide tachykinin receptor antagonists
05/26/1995CA2176708A1 Method of treating neurological disorders
05/26/1995CA2176507A1 Endothelin-converting enzyme
05/24/1995EP0654263A1 Sustained release composition and a method of preparing pharmaceutical compositions
05/24/1995EP0654040A1 Pharmaceutical composition containing botulinum b complex
05/24/1995EP0654033A1 Asymmetrically substituted xanthine with adenosine-antagonistic properties
05/24/1995EP0654029A1 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
05/24/1995EP0654023A1 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists
05/24/1995EP0653942A1 Morphogen-induced nerve regeneration and repair
05/24/1995EP0653940A1 Glial mitogenic factors, their preparation and use
05/24/1995EP0460143B1 Rolipram-containing composition for transdermal application
05/24/1995CN1028531C 2-oxa-1-oxo-8-azaspiro ¾4,5 decane derivatives, pharmaceutical compositions containing them and process for preparing same
05/24/1995CA2136288A1 Imidazopyridazines
05/23/1995US5418248 2-thienylimidazo[2,1-β]benzothiazole-3-acetic acid derivatives, their preparation and their use
05/23/1995US5418241 Antiserotonin agents
05/23/1995US5418237 Indole derivatives
05/23/1995US5418235 Hypotensive, Parkinson's disease, schizophrenia
05/23/1995US5418226 Neuromuscular blocking agent anesthetic, fast-acting
05/23/1995CA1335672C Thioformamide derivatives
05/18/1995WO1995013367A1 Neural axon outgrowth modulators
05/18/1995WO1995013364A1 In situ modification and manipulation of stem cells of the central nervous system
05/18/1995WO1995013291A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage
05/18/1995WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995WO1995013279A1 N-substituted azabicycloalkane derivatives, their preparation and use
05/18/1995WO1995013262A1 Substituted phenyl compounds
05/18/1995WO1995013079A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
05/18/1995WO1995012982A1 Compositions and methods for producing and using homogeneous neuronal cell transplants
05/18/1995CA2176386A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
05/18/1995CA2176363A1 Substituted phenyl compounds
05/18/1995CA2176216A1 Compositions and methods for producing and using homogeneous neuronal cell transplants
05/18/1995CA2175683A1 N-substituted azabicycloalkane derivatives, their preparation and use
05/18/1995CA2175564A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease
05/18/1995CA2173731A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/17/1995EP0653427A1 Galanthamine derivatives, a process for their preparation and their use as medicaments
05/17/1995EP0653203A1 Novel zirconium salts and their synthesis
05/17/1995EP0652893A1 Kininogenase inhibitors
05/17/1995EP0652887A1 New derivatives of neuraminic acid
05/17/1995EP0652879A1 1-azaadamantane derivatives as 5-ht agonists or antagonists
05/17/1995EP0652878A1 Pyridoindolobenzodiazepines and derivatives as antipsychotics
05/17/1995EP0652873A1 Benzodiazepine derivatives
05/17/1995EP0652871A1 Benzodiazepine derivatives
05/17/1995EP0652867A1 Novel pyridyl- and pyrimidylpiperazine derivatives
05/17/1995EP0652866A1 Azacyclic compounds
05/17/1995EP0652765A1 Des-tyr dynorphin analogues
05/17/1995EP0652762A1 Novel anxiolytic
05/17/1995EP0652760A1 Therapeutic methods using caesium ions
05/17/1995EP0652752A1 Water-dispersible tablets
05/17/1995EP0652747A1 Controlled release morphine preparation
05/17/1995EP0486520B1 Dynorphin analogs specific for kappa opioid receptors
05/17/1995CN1102640A Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
05/17/1995CN1028429C Method for preparing of substd. Thieno (2,3-B)(1,5) benzodiazepine derivatives
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995CA1335593C Thieno [2,3-d]azepine derivatives, process for their preparation and pharmaceutical compositions thereof
05/16/1995CA1335591C Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
05/16/1995CA1335590C Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
05/16/1995CA1335577C Superoxide dismutase analogs having novel binding properties
05/16/1995CA1335573C Dispersible tablets of dihydroergotoxine and of acid addition salts thereof
05/11/1995WO1995012591A1 Phenylindole compounds
05/11/1995WO1995012587A1 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
05/11/1995WO1995012576A1 New cyclopropyl derivatives, preparation method thereof and applications
05/11/1995WO1995012417A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
05/11/1995WO1995012402A1 Estrogen compositions and method for neuroprotection
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995WO1995007697A3 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
05/11/1995CA2175795A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
05/11/1995CA2175685A1 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/10/1995EP0651816A1 Blood levels of cck peptides relative to panic disorder treatment
05/10/1995EP0651789A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
05/10/1995EP0651756A1 Tricyclic defem sulphones as elastase inhibitors
05/10/1995EP0651749A1 Imidazole, triazole and tetrazole derivatives
05/10/1995EP0651746A1 Drugs that enhance synaptic responses mediated by ampa receptors
05/10/1995EP0651744A1 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity
05/10/1995EP0651652A1 Treatment for sensitive teeth
05/10/1995EP0542837B1 Propylamine derivatives
05/10/1995CN1028367C Nonsaditive antihistaminics derived from benzimidazoles
1 ... 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 ... 1833